en

PRODUCT DETAIL

Jyseleca 100 mg filmom obalené tablety

Code 5641D
MA number EU/1/20/1480/002
Product Form: tbl flm 90(3x30)x100 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA45 Filgotinib
Shelf life: 48
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 24.09.2020
Validity: 24.09.2025
SmPC + PL: European Medicines Agency's database
Dokument: Jyseleca_prirucka pre zdravotnickych pracovnikov.pdf  
Dokument: Jyseleca_karta pacienta.pdf  
Safety feature Yes
Data update: 25.04.2023
eu-flag.png sk-flag.png